Yong‐Guang Yang

机构：State Grid Corporation of China (China), Jilin University, First Hospital of Jilin University, Model Animal Research Center, Ministry of Education, Jilin International Studies University · ORCID：0000-0003-4985-1247

发表论文 295 篇 · 总被引 13214 次 · h-index 57

代表论文

• Nanocarriers for targeted drug delivery in the vascular system: focus on endothelium (2024 · Journal of Nanobiotechnology · 被引 77)
• Advancing mRNA Therapeutics: The Role and Future of Nanoparticle Delivery Systems (2024 · Molecular Pharmaceutics · 被引 21)
• Optimized lipid nanoparticles enable effective CRISPR/Cas9-mediated gene editing in dendritic cells for enhanced immunotherapy (2024 · Acta Pharmaceutica Sinica B · 被引 20)
• IL-17A/CEBPβ/OPN/LYVE-1 axis inhibits anti-tumor immunity by promoting tumor-associated tissue-resident macrophages (2024 · Cell Reports · 被引 17)
• Long-term engraftment of human stem and progenitor cells for large-scale production of functional immune cells in engineered pigs (2025 · Nature Biomedical Engineering · 被引 10)
• Cationic lipid-modified PEG-PLGA nanoparticles facilitate effective dendritic cell reprogramming to alleviate T cell-mediated autoimmunity in EAE (2025 · Biomaterials · 被引 7)